期刊文献+

复方金铃四逆四物失笑散治疗实验性原发性痛经的作用机制研究 被引量:20

Mechanisms of Fufang Shixiao Formula for Experimental Primary Dysmenorrhea
原文传递
导出
摘要 目的观察临床经验方复方金铃四逆四物失笑散(FFSXF)对原发性痛经模型大鼠子宫的前列腺素和外周血中β-内啡肽(β-EP)的作用,探讨其治疗痛经的作用机制。方法采用苯甲酸雌二醇联合缩宫素制备大鼠原发性痛经模型,以消炎痛、月月舒作对照药,根据FFSXF临床常用剂量,由人与大鼠体重换算后每天分别予FFSXF低、中、高剂量组2.5、5、10 g/kg浓度的FFSXF混悬液灌胃,采用ELISA对照考察药物对子宫组织前列腺素E2(PGE2)、前列腺素F2α(PGF2α)的变化,放射免疫法观察药物对其外周血液中β-EP含量的影响。结果与模型组比较,FFSXF高、中、低剂量组PGE2含量显著上升(P<0.01),PGF2α含量显著下降(P<0.05,P<0.01);FFSXF高、中剂量组β-EP含量显著上升(P<0.01)。结论 FFSXF能有效调节原发性痛经模型大鼠子宫组织中前列腺素水平,同时提高外周血液中的β-EP水平,增强内源性镇痛作用,可能是其治疗原发性痛经的作用机制。 Objective To observe the roles of Fufang Shixiao Formula(FFSXF) in regulating prostaglandin E2(PGE2),prostaglandin F2 alpha(PGF2α),and β-endorphin peptide(β-EP) in rats with primary dysmenorrhea,and to explore its mechanisms for treating primary dysmenorrhea.Methods Primary dysmenorrheal rat model was induced by Estradiol Benzoate combined oxytocin.Indomethacin and Yueyueshu were used as the controls.2.5,5.0,and 10.0 g/kg FFSXF(clinical commonly used dose of FFSXF calculated by converting human weight to rat weight)suspensions were administered to rats in low,middle,high dose FFSXF groups,respectively.Changes of PGE2 and PGF2α in uterus tissue were observed by ELISA.Its effect on β-EP in peripheral blood was observed by radioimmunoassay.Results Compared with the model group,PGE2 content significantly increased(P〈0.01),and PGF2α content significantly decreased in the 3 FFSXF groups(P〈0.05,P〈0.01),and β-EP content significantly increased(P〈0.01) in middle and high dose FFSXF groups.Conclusion FFSXF could effectively regulate prostaglandin level in uterus tissue of primary dysmenorrheal model rats,elevate β-EP content in peripheral blood,strengthen endogenous analgesic effects,which might be its mechanisms for treating primary dysmenorrhea.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2016年第9期1087-1090,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然基金面上项目(No.81373680) 四川省科技厅资助项目(No.2013JY0109)
关键词 复方金铃四逆四物失笑散 原发性痛经 前列腺素 Β-内啡肽 Fufang Shixiao Formula primary dysmenorrhea prostaglandin β-endorphin peptide
  • 相关文献

参考文献15

  • 1Mrugacz G, Grygoruk C, Sieczyf~ski P, et al. Etio- pathogenesis of dysmenorrhea[J].Med Wieku Rozwoj, 2013, 17(1) : 85 -89.
  • 2嵇波,张露芬,朱江,任晓暄,郭孟玮,赵雅芳,徐莉莉,宋晓琳.痛经模型建立和评价方法的思考[J].中国药理学通报,2008,24(6):711-714. 被引量:72
  • 3Park KS, Park KI, Hwang DS, et al. A review of in vitro and in vivo studies on the efficacy of herb- al medicines for primary dysmenorrhea[J]. Evid- Based Complement AIternat Med, 2014: 296860.
  • 4Harel Z. Dysmenorrhea in adolescents and young adults: from pathophysiology to pharmacological treatments and management strategies [J]. Ex- pert Opin Pharmacother, 2008, 9 ( 15): 2661 -2672.
  • 5Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management[J]. Obstet Gyne- col, 2006, 108(2): 428 -441.
  • 6Dawood MY. Dysmenorrhea[J]. Curr Obstetr Gynaecol, 1993, 3(4), 219 -224.
  • 7Lumsden MA, Kelly RW, Baird DT. Primary dys- menorrhoea- The importance of both prostaglan- dins E2 and F2,[J]. Br J Obstetr Gynaecol, 1983, 90(12) : 1135 -1140.
  • 8Coco AS. Primary dysmenorrhea[J].Am Fam Physician, 1999, 60(2) : 489 -496.
  • 9Huang HF, He SN. The progress of study of ute- rus prostaglandin [J].Foreign Med Sci ~ Obstet Gynecol Fascicte), 1995, 22(5): 265-268.
  • 10党海珍,滕久祥,彭芝配,赵桐先.原发性痛经疼痛的中西医研究概况[J].湖南中医学院学报,2000,20(3):70-72. 被引量:25

二级参考文献81

共引文献192

同被引文献247

引证文献20

二级引证文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部